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Aims Heterozygous mutations in KCNQ1 cause type 1 long QT syndrome (LQT1), a disease characterized by prolonged
heart rate-corrected QT interval (QTc) and life-threatening arrhythmias. It is unknown why disease penetrance and
expressivity is so variable between individuals hosting identical mutations. We aimed to study whether this can be
explained by single nucleotide polymorphisms (SNPs) in KCNQ1’s 3′ untranslated region (3′UTR).
Methods
and results
This study was performed in 84 LQT1 patients from the Academic Medical Center in Amsterdam and validated in 84
LQT1 patients from the Mayo Clinic in Rochester. All patients were genotyped for SNPs in KCNQ1’s 3′UTR, and six
SNPs were found. Single nucleotide polymorphisms rs2519184, rs8234, and rs10798 were associated in an allele-
speciﬁc manner with QTc and symptom occurrence. Patients with the derived SNP variants on their mutated
KCNQ1 allele had shorter QTc and fewer symptoms, while the opposite was also true: patients with the derived
SNP variants on their normal KCNQ1 allele had signiﬁcantly longer QTc and more symptoms. Luciferase reporter
assays showed that the expression of KCNQ1’s 3′UTR with the derived SNP variants was lower than the expression
of the 3′UTR with the ancestral SNP variants.
Conclusion Our data indicate that 3′UTR SNPs potently modify disease severity in LQT1. The allele-speciﬁc effects of the SNPs
on disease severity and gene expression strongly suggest that they are functional variants that directly alter the ex-
pression of the allele on which they reside, and thereby inﬂuence the balance between proteins stemming from either
the normal or the mutant KCNQ1 allele.
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Long QT syndrome (LQTS) is the most common heritable cardiac
channelopathy, and can cause premature sudden death due to life-
threatening arrhythmias in relation to prolongation of the heart
rate-corrected QT interval (QTc).
1 The most prevalent form,
LQT1, is caused by loss-of-function mutations in the
KCNQ1-encoded Kv7.1 potassium channel (IKs).
2,3
LQT1 is characterized by incomplete penetrance and variable
expressivity whereby family members carrying identical mutations
have profound differences in their QTc and clinical course.
4,5 The
cause for this heterogeneity remains largely elusive. Kv7.1 is a tetra-
meric channel resulting from the post-translational assembly of
four KCNQ1-encoded subunits. Therefore, patients heterozygous
for an LQT1-causative mutation combine the translated products
from normal and LQT1-mutation-containing alleles to form tetra-
meric channels. If both alleles are similarly expressed, one would
predict that 2/16 of the Kv7.1 channels stem solely from either
the normal or the mutated allele. The remaining channels are
hybrids of the healthy and the mutated alleles. This reasoning pre-
dicts that factors that inﬂuence the balance between normal and
mutant allele expression affect the proportion of mutated
protein in the Kv7.1 channels, and thereby modify disease severity.
We hypothesized that single nucleotide polymorphisms (SNPs)
in KCNQ1’s 3′ untranslated region (3′UTR) modify the relative ex-
pression of normal vs. LQT1-mutation-containing allele and
thereby contribute to disease variability. The 3′UTR is known to
play an important regulatory role in gene expression, in particular
by controlling mRNA stability and translation.
6,7 Heterozygosity
for SNPs in the 3′UTR may alter the regulatory effects of the
3′UTR on gene expression in an allele-speciﬁc manner, and this
is expected to be especially relevant when one allele contains a
disease-causing mutation. In the case of LQT1, 3′UTR SNP variants
residing on either the healthy or the mutated allele may alter the
relative number of Kv7.1 channel subunits stemming from either
allele. We therefore hypothesized that SNPs in KCNQ1’s 3′UTR
could affect 3′UTR function, and thereby modify the disease
phenotype in an allele-speciﬁc fashion. We initially assessed this
in LQT1 patients from the Academic Medical Center (AMC) in
Amsterdam (the Netherlands) and validated our ﬁndings in
patients from the Mayo Clinic (MC) in Rochester (MN, USA).
Methods
Patient inclusion
From both institutions (AMC and MC), we included families where a
mutation in KCNQ1 was identiﬁed in at least three members, and at
least one affected member displayed QTc prolongation. Genomic
DNA (if available) was used for sequencing the 3′UTR of KCNQ1.
This data were used to determine whether 3′UTR SNP variants
occur in trans (opposite allele) or in cis (on the same allele) as the
pathogenic KCNQ1 mutation (as deﬁned by analysis of phase in the
families). From each family, at least three members were genotyped
(unless patients were homozygous for the SNP variants). Next, we
included those patients in whom the KCNQ1 mutation was the only
mutation present in a LQTS-linked gene, and in whom a 12-lead
ECG and clinical data were available for analysis. All patients
(and their family members) with double and compound mutations in
major LQT-susceptibility genes (i.e. KCNH2, SCN5A, KCNE1, and
KCNE2) were excluded. Individuals with acquired cardiac diseases,
electrolyte abnormalities, or repolarization prolonging medication
were also excluded. The following clinical parameters were obtained
from medical records: age, gender, proband status, family history of
sudden cardiac death at age ,45 years, incidence of Torsades des
Pointes, VF, and/or syncope, and type of KCNQ1 mutation. The
researchers who obtained clinical parameters (and those who analysed
ECGs) were blind to the 3′UTR SNP haplotypes. The study was
approved by the institutional review committees and the subjects
had given informed consent.
Genetic analysis
LQT1-associated KCNQ1 mutations had been identiﬁed previously
using standard protocols.
8 For this study, the ﬁnal exon and the
3′UTR of KCNQ1 were additionally sequenced. The region to be ana-
lysed comprised of three amplicons, and was ampliﬁed with polymer-
ase chain reaction (PCR) using oligonucleotide pairs: 5′-GGCACC
TTCCCTTCTCTGG-3′ with 5′-ACCACCATGCCAGTGATGTC-3′,
5′-CACAGCCTGCACTTGGG-3′ with 5′-CAGGGCTCCTCTCCA
GC-3′, and 5′-CAGTCTCACCATTTCCCCAG-3′ with 5′-GCCCA
GAACAGGAGCGAC -3′.
ECG analysis
Twelve-lead electrocardiograms were enlarged to facilitate
manual analysis. QT duration (lead II or V5) was corrected for heart
rate using Bazett’s formula (QTc ¼ QT/
p
RR, where RR is the
interval, measured in seconds, from the onset of 1 QRS complex to
the onset of the following QRS complex). To measure QTc within
each individual, the mean value of ﬁve consecutive beats was
calculated.
The effect of SNPs on QTc in the general
population
To study the effect of SNPs rs2519184, rs8234, and rs10798 in the
general population, we contacted the investigators of the KORA
Study to evaluate whether the SNPs rs2519184, rs8234, or rs10798
are correlated with the QTc duration in the general population. The
KORA Study is a series of independent population-based epidemio-
logical surveys of participants residing in the region of Augsburg,
Southern Germany. All survey participants had German nationality,
were identiﬁed through the registration ofﬁce, and were examined in
1994–95 (KORA S3) and 1999–2001 (KORA S4). In 2004–05, 3006
subjects participated in a 10-year follow-up examination of S3
(KORA F3). Individuals for genotyping in KORA F3 and KORA S4
were randomly selected.
Luciferase reporter assay
Plasmid construction
Luciferase reporter plasmids were constructed by PCR ampliﬁcation of
the 3′UTR of KCNQ1 from a patient heterozygous for the SNPs
rs2519184, rs8234, and rs10798 with the primers: 5′-ACTGACT
AGTCATGGACCATGCTGTCTG-3′ and 5′-ACTGGAGCTCCAGC
CTGTGATTCTCCACG-3′. This 878 bp fragment was cloned into
the pMIR-REPORT
TM Luciferase vector (Ambion) downstream of
the luciferase coding region, creating luciferase KCNQ1-3′UTR-G-A-A
(ancestral haplotype) and luciferase KCNQ1-3′UTR-A-G-G (derived
haplotype). The plasmids luciferase KCNQ1-3′UTR-A-A-A, luciferase
KCNQ1-3′UTR-G-G-A, and luciferase KCNQ1-3′UTR-G-A-G were
Variants in the 3’ untranslated region of the KCNQ1-encoded Kv7.1 715generated from the luciferase KCNQ1-3′UTR-G-A-A plasmid by
PCR-based mutagenesis.
Cell isolation and preparation
Neonatal rat cardiac myocytes, immortalized with a temperature-
sensitive SV40 T antigen (H10 cells),
9 were cultured in Dulbeccos
modiﬁed Eagles medium supplemented with 10% Fetal Calf Serum
(Gibco-BRL) and glutamine at 338C. One day prior to transfection,
cells were seeded in a 24-well plate at a density of 1.4 × 10
6 cells
per plate. Cardiomyocytes from 1 to 2-day-old Lewis neonatal rats
were isolated and cultured as described previously.
10
Transfection and luciferase assay
H10 cells were transiently transfected per well with 5 ng Renilla luci-
ferase plasmid, phRL vector (Promega), and 5 ng or 10 ng of either
luciferase KCNQ1-3′UTR-G-A-A, luciferase KCNQ1-3′UTR-A-A-A,
luciferase KCNQ1-3′UTR-G-G-A, luciferase KCNQ1-3′UTR-G-A-G,
or luciferase KCNQ1-3′UTR-A-G-G using GeneJammer (Agilent Tech-
nologies). Neonatal rat cardiomyocytes were transfected with 50 ng
Renilla luciferase plasmid, phRL vector, and 100 ng of either luciferase
KCNQ1-3′UTR-G-A-A, luciferase KCNQ1-3′UTR-A-A-A, luciferase
KCNQ1-3′UTR-G-G-A, luciferase KCNQ1-3′UTR-G-A-G, or lucifer-
ase KCNQ1-3′UTR-A-G-G using lipofectamine 2000 reagent (Invitro-
gen). At 48 h after transfection, cells were lysed and assayed for
luciferase and Renilla luciferase activity with a luminometer (Glomax
multi detection system, Promega) by using the Renilla reporter assay
system (Promega). Renilla luciferase activity was assayed to normalize
luciferase results for cell densities and transfection efﬁciency. The luci-
ferase assays were performed at least three times, and in every experi-
ment plasmids were isolated from three different colonies per
haplotype. Per plasmid, four wells were transfected and the average
signal of these four wells was used for the statistical analysis.
Statistical methods
QTc was compared between various LQT1 genotype and 3′UTR SNP
haplotype combinations. We used a linear mixed effect regression
model from the kinship package in R.
11 Differences in symptom preva-
lence were analysed with a logistic regression model using generalized
estimation equations. In both models, a correction for the relatedness
among individuals was applied. Furthermore, age at the time of ECG,
gender, and proband status were included as covariates and genotype
effects were modelled as additive effects. For the in vitro experiments,
differences between groups were compared using analysis of variance
(ANOVA) or Student’s t-test, where appropriate. Values are expressed
as mean+standard error. We regarded P-values , 0.05 as statistically
signiﬁcant.
RESULTS
Patient inclusion and KCNQ1 3′UTR
SNP detection
From AMC, 84 LQT1-positive subjects from 24 families were
included. From MC, 84 LQT1-positive subjects from 17 families
were included. Demographic data and details of the identiﬁed
mutations are displayed in Table 1 and Supplementary material
online, Table S1, respectively. In all subjects, the ﬁnal exon and
the complete 3′UTR of KCNQ1 were sequenced. In the AMC
cohort, seven SNPs were found of which six SNPs were in the
3′UTR. Single nucleotide polymorphisms at nucleotide positions
403092 and 403641 were not reported previously (NCBI build
36, hg18). Except for the SNP at nucleotide position 403092, all
SNPs (and no additional SNPs) were also found in the MC
cohort (Figure 1; see Table 2 for SNP frequencies). Single nucleo-
tide polymorphisms rs8234 and rs10798 were in complete
linkage disequilibrium in all patients in this study.
Association between KCNQ1 3′UTR SNPs
and QTc in LQT1 patients
Next, we studied whether the three most frequent SNPs, for
which group sizes in both the AMC and MC cohorts were large
enough for statistical analysis, were associated with QTc. We
hypothesized that SNP variants would modify the QTc depending
on whether they occur in trans (opposite allele) or in cis (on the
same allele) as the pathogenic KCNQ1 mutation as deﬁned by ana-
lysis of phase in the families.
The presence of the derived variant of rs2519184 (A) in trans to
the mutated allele was indeed associated with a marked increase in
QTc by 46+16 ms in the AMC cohort (P ¼ 0.005; Figure 2A). This
was corroborated by similar ﬁndings in the MC cohort where the
derived variant in trans was associated with 60+16 ms longer
QTc (P , 0.001; Figure 2D). Notably, in the MC cohort, we also
................................................................................
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Table 1 Clinical characteristics, mutation types, and
ECG parameters of the study populations from the
AMC and the Mayo Clinic
Variable AMC Mayo
Clinical characteristics
Patients, n (%) 84 (100) 84 (100)
Male/female, n 34/50 38/46
Age, years 34+32 7 +2
Proband, n (%) 22 (26) 13 (15)
Family history for sudden death, n (%) 40 (48) 58 (69)
Syncope, n (%) 18 (21) 18 (21)
Documented TdP/VF, n (%) 5 (6) 1 (1)
Mutation type
Missense, n (%) 63 (75) 67 (80)
Frameshift, n (%) 7 (8) 1 (1)
Splice site, n (%) 11 (13) 4 (5)
Deletion, n (%) 3 (4) 12 (14)
ECG parameters
RR interval (ms) 859+19 917+24
Males 879+26 968+41
Females 844+28 875+27
QT duration (ms) 411+7 426+6
Males 405+8 429+10
Females 416+10 425+8
QTc (ms) 446+7 451+4
Males 435+6 445+6
Females 454+7
a 457+4
a
aStatistical signiﬁcance compared with males.
Values are expressed as number of patients (percentage of total), or as mean+
standard error of the mean (SEM).
A.S. Amin et al. 716identiﬁed subjects where this derived variant resided on the
LQT1-mutation containing allele. Here, location of this variant in
cis was associated with 16+8 ms shorter QTc (P , 0.001).
The same effects were seen for SNPs rs8234 and rs10798.
When the derived variants of rs8234 and rs10798 (G-G) were
in trans to the mutated allele, QTc was increased by 26+10 ms
(P ¼ 0.010; Figure 2B). Again, this was conﬁrmed in the MC
cohort where the derived variants located in trans increased the
QTc by 33+7m s( P , 0.001; Figure 2E). The opposite location
of the derived variants (i.e. in cis to the mutation) was related
with shorter QTc (241+25 ms; not signiﬁcant), which was con-
ﬁrmed in the MC population (reduction by 9+9 ms; not
signiﬁcant).
Allele-speciﬁc haplotype analysis revealed that location of the
derived variants of the SNPs (A-G-G) in trans to the mutation
was associated with 49+16 ms longer QTc in the AMC cohort
(P ¼ 0.003) and 60+14 ms longer QTc in the MC cohort (P ,
0.001; Figure 2C and F). Subjects where the A-G-G haplotype
was in cis to the mutation were only present in the MC cohort.
Indeed, in these subjects, the anticipated opposite effect on QTc
Figure 1 Genetic variation in the 3′ untranslated region of KCNQ1. Single nucleotide polymorphisms (SNPs) found in the study cohorts of the
Academic Medical Center Amsterdam (AMC) and the Mayo Clinic (MC). Position of the nucleotide change is starting from the ATG start codon
(NCBI build 36, hg18).
............................. ..............................
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Table 2 Single nucleotide polymorphisms found in the 3′untranslated region of KCNQ1
Genetic
location
Nucleotide
change position
Allele (ancestral/
derived)
SNP id Genotype AMC (n 5 84) Mayo (n 5 84)
N (%) Minor allele
frequency
N (%) Minor allele
frequency
Exon 16 402865 C/T rs11601907 CC 38 (45) 0.327 50 (60) 0.214
CT 37 (44) 32 (38)
TT 9 (11) 2 (2)
3′UTR 403092 G/A Not available GG 81 (96) 0.018 84 (100) 0.000
GA 3 (4) 0
AA 0 0
3′UTR 403321 C/T rs45460605 CC 81 (96) 0.018 83 (99) 0.006
CT 3 (4) 1 (1)
TT 0 0
3′UTR 403389 G/A rs2519184 GG 78 (93) 0.036 50 (60) 0.202
GA 6 (7) 34 (40)
AA 0 0
3′UTR 403641 G/A Not available GG 83 (99) 0.006 83 (99) 0.006
GA 1 (1) 1 (1)
AA 0 0
3′UTR 403785 A/G rs8234 AA 52 (62) 0.208 31 (37) 0.351
AG 29 (34) 47 (56)
GG 3 (4) 6 (7)
3′UTR 403842 A/G rs10798 AA 52 (62) 0.208 31 (37) 0.351
AG 29 (34) 47 (56)
GG 3 (4) 6 (7)
Position of the nucleotide change is starting from the ATG start codon (NCBI build 36, hg18). The SNP id denotes single nucleotide polymorphism identity from public databases.
N (%) denotes number of patients (percentage of total).
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cant). Various allele-speciﬁc haplotype combinations of KCNQ1
and the derived SNP variants, as shown in Figure 2C and F, displayed
an intermediate effect on QTc. Finally, the effects of SNPs
rs2519184, rs8234, and rs10798 on QTc in the combined study
population (both AMC and MC) are shown in the Supplementary
material online, Figure S1.
Since our study cohorts included LQT-1 patients with differ-
ent types of mutation in KCNQ1, we analysed whether the effect
of the 3′UTR SNPs on QTc is signiﬁcantly different for different
mutation types or whether this effect is different between car-
riers of a missense mutation vs. carriers of a frameshift, splice
site, or deletion mutation. The effect of the SNPs on QTc
was not signiﬁcantly different for different mutation types (P ¼
0.118 for rs2519184, P ¼ 0.493 for rs8234 and rs10798, and
P ¼ 0.148 for all three SNPs), and was also not different
between carriers of a missense mutation vs. carriers of a frame-
shift, splice site, or deletion mutation (P ¼ 0.118 for rs2519184,
P ¼ 0.493 for rs8234 and rs10798, and P ¼ 0.148 for all three
SNPs).
Association between KCNQ1 3′
untranslated region single nucleotide
polymorphisms and QTc in single families
Our data suggest that assessing these 3′UTR SNPs can predict
disease severity of a given KCNQ1 mutation in one family. To
test this, we analysed the allele-speciﬁc haplotype of SNPs
rs2519184, rs8234, and rs10798 with regard to QTc in three fam-
ilies with more than 10 members affected, including one family
with the KCNQ1-R243C mutation (14 affected), one family with
the KCNQ1-I235N mutation (20 members), and one family
with the KCNQ1-339delF mutation (12 affected). Indeed, the
KCNQ1-R243C carriers where the derived variants of the SNPs
(A-G-G or G-G-G) were found in trans to the mutation exhibited
markedly longer QTc than their KCNQ1-R243C-positive relatives
who did not carry these variants (P , 0.001; Figure 3A, see Supple-
mentary material online, Figure S2a for family pedigree). The op-
posite was seen in the family with the KCNQ1-I235N mutation,
where all affected members carried the derived variants of the
3′UTR SNPs (A-G-G) on their mutation-containing allele.
Figure 2 Allele-speciﬁc effects of single nucleotide polymorphisms (SNPs) rs2519184, rs8234, and rs10798 on QTc. Allele-speciﬁc effects of
SNPs rs2519184, rs8234, and rs10798 on QTc are displayed in panels (A and B) and (C) for the AMC population, and (D and E), and (F) for the
MC population. Effects of SNP rs2519184 are displayed in (A) and (D). Effects of SNPs rs8234 and rs10798 are displayed in (B) and (E). Allele-
speciﬁc haplotype analysis of the three SNPs is displayed in (C) and (F). The red line represents mean QTc of all individuals regardless of the
speciﬁc LQT1-causative mutation and the 3′ untranslated region SNP status. Numbers below genotypes denote group sizes. Data are presented
as mean; I bars represent standard errors. N, normal KCNQ1 allele; M, mutant KCNQ1 allele; green box, ancestral SNP variant; yellow box,
derived SNP variant.
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tion displayed mostly normal to near-normal QTc values, while
members who were homozygous for the derived variants of
SNPs rs8234 and rs10798 (thus carrying these variants also on
their healthy allele) displayed longer QTc values (P ¼ 0.129;
Figure 3B, see Supplementary material online, Figure S2b for
family pedigree). Finally, in the KCNQ1-339delF family, members
with the derived SNP variants (A-G-G or G-G-G) in trans to the
mutation exhibited longer QTc than their relatives who were
homozygous for the ancestral SNP variants (P ¼ 0.001; Figure 3C;
see for family pedigree Supplementary material online, Figure S2c).
Association between KCNQ1 3′
untranslated region single nucleotide
polymorphisms and symptomatology
in LQT1 patients
Next, we assessed in the total combined study population (AMC
and MC) whether allele-speciﬁc location of the derived SNP var-
iants in the KCNQ1’s 3′UTR also modiﬁes the known cardiac se-
quelae of LQT1 [unexplained syncope, documented torsades de
pointes ventricular tachycardia/ventricular ﬁbrillation, and/or
(aborted) sudden death]. Location of the derived haplotype of
SNPs rs8234 and rs10798 (G-G-G) in trans to the mutation was
associated with a statistically signiﬁcant increased occurrence of
symptoms (P ¼ 0.004). Inversely, the opposite location of the
derived SNP haplotype (i.e. in cis to the mutation) tended to be
related to fewer symptoms (not signiﬁcant; Figure 4). Additionally,
we corrected the effects of the 3′UTR SNPs on symptomatology
also for QTc (thus not only for age, sex, and proband status). Inter-
estingly, after correction for QTc, the 3′UTR haplotype was still
associated with the occurrence of symptoms (Supplementary ma-
terial online, Figure S3).
The effect of single nucleotide
polymorphisms rs2519184, rs8234, and
rs10798 on QTc in the general population
To study the effect of SNPs rs2519184, rs8234, and rs10798 in the
general population, we evaluated whether the SNPs rs2519184,
rs8234, or rs10798 are correlated with the QTc duration in two
populations of the KORA study (KORA F3 and KORA S4). The
data about rs2519184 have been published previously.
12 This
study indeed found a correlation between the SNP and QTc dur-
ation in their screening sample of 689 individuals, but this associ-
ation was not found in a conﬁrmation sample of 3277 individuals.
Our novel analysis in the KORA study populations showed that
rs8234 and rs10798 were not associated with QTc duration in
KORA F3 and KORA S4 (Table 3).
In vitro effects of KCNQ1 3′ untranslated
region single nucleotide polymorphism
on expression
Since the above shows that the derived variants of SNPs
rs2519184, rs8234, and rs10798 attenuate QTc prolongation
when they are located in cis (i.e. on the same allele) to the
LQT1 mutation, but aggravate QTc prolongation when located in
trans (i.e. on the normal allele) to the mutation, we hypothesized
that these SNP variants suppress the expression of the alleles on
which they reside. Thus, the occurrence of these ‘suppressive’
3′UTR variants in cis to the LQT1 mutation may attenuate QTc
prolongation by decreasing the abundance of mutant protein
Figure 3 Allele-speciﬁc effects of single nucleotide polymorphisms (SNPs) rs2519184, rs8234, and rs10798 on QTc in three single families.
Allele-speciﬁc haplotype analysis of SNPs rs2519184, rs8234, and rs10798 with regard to QTc are displayed for the three largest families: one
family carrying the KCNQ1-R243C mutation (A), one family with the KCNQ1-I235N mutation (B), and one family carrying the
KCNQ1-339delF mutation (C). Numbers below genotypes denote group sizes. Data are presented as mean; I bars represent standard
errors. N, normal KCNQ1 allele; M, mutant KCNQ1 allele; green box, ancestral SNP variant; yellow box, derived SNP variant.
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iants in trans to the mutation exerts the opposite effects on QTc
by decreasing expression of the normal allele and thereby increas-
ing the relative amount of mutant Kv7.1 subunits. To test this hy-
pothesis, we cloned KCNQ1’s 3′UTR with the ancestral 3′UTR
haplotype (G-A-A) or the derived haplotype (A-G-G) of SNPs
rs2519184, rs8234, and rs10798 downstream of the luciferase
coding region in the pMIR-REPORT
TM plasmid (Ambion), and
transfected these plasmids into both primary neonatal rat cardio-
myocytes (Figure 5A) and heart-derived H10 cells (Supplementary
material online, Figure S4a). The plasmid containing the derived
3′UTR haplotype (A-G-G) had signiﬁcantly lower luciferase activity
in both cell types (P ¼ 0.049 and P ¼ 0.032, respectively). More-
over, introduction of either derived variant of SNP rs2519184,
rs8234, or rs10798 into the ancestral haplotype was sufﬁcient to
decrease luciferase activity, indicating that those three nucleotides
can separately suppress the expression of KCNQ1 (Figure 5A and
Supplementary material online, Figure S4b).
Discussion
This study shows that SNPs rs2519184, rs8234, and rs10798 in the
3′UTR of KCNQ1 modify the clinical effects of mutations in LQT1.
The modifying effects of these SNPs on disease severity are robust
and depend on the KCNQ1 allele on which they reside. When the
SNPs are on the allele that contains the mutation, disease is less
severe. Oppositely, when they reside on the healthy allele (free
of the LQT1-causing mutation), the disease is clearly aggravated.
Our in vitro experiments indicate that the derived variants of the
SNPs suppress expression. This suggests that these SNPs modify
disease severity in an allele-speciﬁc manner, by suppressing the
allele on which they reside. The clear effects obtained by the iso-
lated SNPs in vitro strongly suggest that they are functional and that
the clinical effect is a direct consequence of these SNPs rather than
being caused by distant genetic variation. Taken together, our data
suggest that with the SNPs on the mutated allele, this mutated
allele is suppressed and the expressed LQT1 phenotype is less
Figure 4 Allele-speciﬁc effects of single nucleotide polymorphisms (SNPs) rs2519184, rs8234, and rs10798 on symptomatology. Allele-
speciﬁc effects of SNPs rs2519184, rs8234, and rs10798 with regard to the occurrence of cardiac symptoms [unexplained syncope, documen-
ted torsades de pointes ventricular tachycardia/ventricular ﬁbrillation, and/or (aborted) sudden death] are shown in the total combined study
population (AMC and MC). Effects of SNP rs2519184 are displayed in (A). Effects of SNPs rs8234 and rs10798 are displayed in (B). Allele-
speciﬁc haplotype analysis of the three SNPs with regard to the occurrence of symptoms is displayed in (C). Numbers below genotypes
denote group sizes. Data are presented as mean; I bars represent standard errors. N, normal KCNQ1 allele; M, mutant KCNQ1 allele; green
box, ancestral SNP variant; yellow box, derived SNP variant.
...............................................................................................................................................................................
Table 3 The effect of single nucleotide polymorphisms rs8234 and rs10798 on QTc in the general population
SNP Population* Number Ancestral allele/haplotype Derived allele/haplotype MAF Effect on QTc Beta (ms) P-value
rs8234 KORA F3 1459 A G 0.3041 20.573105 0.52
rs10798 KORA F3 1459 A G 0.304 20.572674 0.52
rs8234 KORA S4 975 A G 0.3216 1.383768 0.13
rs10798 KORA S4 975 A G 0.3209 1.42896 0.12
Haplotype KORA F3 1459 AA GG 0.3047 0.569323 0.52
Haplotype KORA S4 975 AA GG 0.3185 0.611701 0.42
Number, number of individuals within the screening sample; MAF, minor allele frequency. The effect on the QTc duration refers to the dosage (i.e. expected number of copies) of
the major allele. The QTc duration is calculated by the Bazett’s formula, and is corrected for age and gender.
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allele opposite to the mutation, then this healthy allele is sup-
pressed and the LQT1 phenotype is more severe (Figure 6). Fur-
thermore, the 3′UTR SNPs were still associated with the
occurrence of symptoms even after correction for QTc, suggesting
that the SNPs may play a role in the occurrence of symptoms not
only by modifying the baseline QTc but possibly also by modifying
the response to arrhythmogenic triggers.
In line with our data, it has been previously shown in lympho-
blastoid cell lines that the KCNQ1 allele containing the ancestral
variant of SNP rs10798 is expressed three-fold higher than the
allele with the derived variant of the SNP.
13 Although in this
study, differences in allelic expression of KCNQ1 were attributed
to genetic imprinting (i.e. preferential expression of the maternal
allele), genetic imprinting seems less likely to explain the cardiac
effects as Lee et al.
14 have shown that KCNQ1 is not imprinted
in the heart. Moreover, if imprinting would explain the allele-
speciﬁc disease-modifying effects of the 3′UTR SNPs,
LQT1-positive subjects who have inherited the mutation from
their father would be expected to have less severe phenotype.
However, this was not the case for our LQT1 patients (as exem-
pliﬁed in Supplementary material online, Figures S2).
Our ﬁndings imply that LQT1 genetic testing should include ana-
lysis and cis/trans phase determination of suppressive 3′UTR SNPs
in KCNQ1. More generally, our study shows that genetic variation
in the 3′UTR may be an important source for clinical variability by
altering the balance of expression between two alleles. This is the
ﬁrst clinical conﬁrmation of previous predictions that genetic vari-
ation in the 3′UTR may be an essential source for ‘Darwinian
ﬁtness’, and hence individual variation in disease severity.
7 Earlier
reports have linked 3′UTR SNPs to various acquired diseases but
could not establish allele-speciﬁc effects of the SNPs.
15,16 Further-
more, other genetic factors have been shown to modify QTc in
LQT1, e.g. SNPs in intronic regions of KCNQ1,
12 and variants in
genes encoding (putative) ion channel regulatory subunits, such
as NOS1AP which encodes a nitric oxide synthase adaptor
protein.
17 However, it is noteworthy that the size of the effects
on QTc and symptoms described here go well beyond what has
been shown for genetics modiﬁers described previously.
Since the suppressive SNPs are expected to decrease overall
Kv7.1 levels, we explored whether SNPs rs2519184, rs8234, and
rs10798 were related to QTc in two populations from the
KORA study.
12 However, no relation with QTc was found in
these populations, suggesting that the suppressive effects of
these SNPs do not lower Kv7.1 sufﬁciently to induce QTc pro-
longation in healthy individuals.
In conclusion, we show that naturally occurring SNPs in
KCNQ1’s 3′UTR suppress gene expression in an allele-speciﬁc
manner. In KCNQ1-mutation carriers, these functional SNPs may
alter the balance between the two alleles. This may explain an
Figure 5 The functional effects of genetic variation in the 3′untranslated region (3′UTR) of KCNQ1 in vitro.( A) Luciferase assays in primary
neonatal rat cardiomyocytes transfected with two independent reporter plasmids containing either the ancestral or the derived haplotype of
single nucleotide polymorphisms (SNPs) in KCNQ1’s 3′UTR. Observed differences in luciferase activity between the ancestral and derived
haplotype suggest that expression is inhibited. (B) Luciferase assays in neonatal rat cardiomyocytes transfected with a reporter plasmid contain-
ing either the ancestral haplotype of the 3′UTR of KCNQ1 or the same reporter where the SNPs rs2519184, rs8234, and rs10798 were sep-
arately changed to the derived allele. Introducing either of the derived SNP variants was sufﬁcient to decrease the luciferase activity. Data are
presented as means; I bars denote standard errors. Green box, ancestral SNP variant; yellow box, derived SNP variant.
Variants in the 3’ untranslated region of the KCNQ1-encoded Kv7.1 721important part of the incomplete penetrance and variable expres-
sivity associated with LQT1. Our ﬁndings suggest that the clinical
effects of a pathogenic mutation may be determined by naturally
occurring genetic variation in its 3′UTR which results in the alter-
ation of normal or mutant allele expression. This ﬁnding also sug-
gests that in autosomal dominant diseases like LQTS, disease
severity can be importantly modiﬁed by allelic imbalance induced
by sequence variation in the 3′UTR stemming from the unaffected
parent.
Supplementary material
Supplementary material is available at European Heart Journal
online.
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